These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 27196586

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
    Scott N, Ólafsson S, Gottfreðsson M, Tyrfingsson T, Rúnarsdóttir V, Hansdottir I, Hernandez UB, Sigmundsdóttir G, Hellard M.
    J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.
    Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Mabileau G, Dhersin JS, Yazdanpanah Y.
    J Viral Hepat; 2018 Oct; 25(10):1197-1207. PubMed ID: 29660211
    [Abstract] [Full Text] [Related]

  • 6. What is required for achieving hepatitis C virus elimination in Singapore? A modeling study.
    Chaillon A, Thurairajah PH, Hsiang JC, Martin NK.
    J Gastroenterol Hepatol; 2021 Apr; 36(4):1110-1117. PubMed ID: 32777859
    [Abstract] [Full Text] [Related]

  • 7. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA, Anderson J, Kerr CC, Thein HH, Zhang L, Iversen J, Dore GJ, Kaldor JM, Law MG, Maher L, Wilson DP.
    AIDS; 2012 Nov 13; 26(17):2201-10. PubMed ID: 22914579
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of the HepCATT intervention in specialist drug clinics to improve case-finding and engagement with HCV treatment for people who inject drugs in England.
    Ward Z, Reynolds R, Campbell L, Martin NK, Harrison G, Irving W, Hickman M, Vickerman P.
    Addiction; 2020 Aug 13; 115(8):1509-1521. PubMed ID: 31984606
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico.
    Marquez LK, Fleiz C, Burgos JL, Cepeda JA, McIntosh C, Garfein RS, Kiene SM, Brodine S, Strathdee SA, Martin NK.
    Addiction; 2021 Oct 13; 116(10):2734-2745. PubMed ID: 33620750
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.
    Barbosa C, Fraser H, Hoerger TJ, Leib A, Havens JR, Young A, Kral A, Page K, Evans J, Zibbell J, Hariri S, Vellozzi C, Nerlander L, Ward JW, Vickerman P.
    Addiction; 2019 Dec 13; 114(12):2267-2278. PubMed ID: 31307116
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?
    Martin NK, Boerekamps A, Hill AM, Rijnders BJA.
    J Int AIDS Soc; 2018 Apr 13; 21 Suppl 2(Suppl Suppl 2):e25062. PubMed ID: 29633560
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands.
    Helsper CW, Janssen MP, van Essen GA, Croes EA, van der Veen C, de Wit AG, de Wit NJ.
    Int J Drug Policy; 2017 Sep 13; 47():117-125. PubMed ID: 28826994
    [Abstract] [Full Text] [Related]

  • 16. Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies.
    Krauth C, Rossol S, Ortsäter G, Kautz A, Krüger K, Herder B, Stahmeyer JT.
    BMC Infect Dis; 2019 Dec 02; 19(1):1019. PubMed ID: 31791253
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I, Sypsa V, Papatheodoridis G, Souliotis K, Athanasakis K, Razavi H, Hatzakis A.
    World J Gastroenterol; 2019 Mar 21; 25(11):1327-1340. PubMed ID: 30918426
    [Abstract] [Full Text] [Related]

  • 19. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Echevarria D, Gutfraind A, Boodram B, Layden J, Ozik J, Page K, Cotler SJ, Major M, Dahari H.
    Vaccine; 2019 May 01; 37(19):2608-2616. PubMed ID: 30962092
    [Abstract] [Full Text] [Related]

  • 20. Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco.
    Fraser H, Stone J, Facente SN, Artenie A, Patel S, Wilson EC, McFarland W, Page K, Vickerman P, Morris MD.
    Int J Drug Policy; 2024 Sep 01; 131():104452. PubMed ID: 38910096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.